Ana Lleò

12.8k total citations
138 papers, 5.2k citations indexed

About

Ana Lleò is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Ana Lleò has authored 138 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Hepatology, 58 papers in Epidemiology and 48 papers in Surgery. Recurrent topics in Ana Lleò's work include Liver Diseases and Immunity (58 papers), Liver Disease Diagnosis and Treatment (52 papers) and Pediatric Hepatobiliary Diseases and Treatments (23 papers). Ana Lleò is often cited by papers focused on Liver Diseases and Immunity (58 papers), Liver Disease Diagnosis and Treatment (52 papers) and Pediatric Hepatobiliary Diseases and Treatments (23 papers). Ana Lleò collaborates with scholars based in Italy, United States and United Kingdom. Ana Lleò's co-authors include Pietro Invernizzi, M. Eric Gershwin, Mauro Podda, M. Eric Gershwin, Ilaria Bianchi, Carlo Selmi, Ross L. Coppel, Aftab A. Ansari, Luca Moroni and Alessio Aghemo and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Ana Lleò

135 papers receiving 5.1k citations

Peers

Countries citing papers authored by Ana Lleò

Since Specialization

Citations

This map shows the geographic impact of Ana Lleò's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Lleò with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Lleò more than expected).

Fields of papers citing papers by Ana Lleò

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Lleò. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Lleò. The network helps show where Ana Lleò may publish in the future.

Co-authorship network of co-authors of Ana Lleò

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Lleò. A scholar is included among the top collaborators of Ana Lleò based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Lleò. Ana Lleò is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world experience with odevixibat in children with progressive familial intrahepatic cholestasis 2024 ·JHEP Reports ·Angelo Di Giorgio, Marco Sciveres, (unknown), Pier Luigi Calvo, Mara Cananzi, Ana Lleò, Simona Gatti, Giuseppe Indolfi, Annalisa Madeo, Claudia Mandato, Federica Nuti, Chiara Zanchi, Greta Carioli, Arianna Ghirardi, Emanuele Nicastro, Lorenzo D’Antiga	3
2	Is ChatGPT-4 a Reliable Tool in Autoimmune Hepatitis? 2024 ·The American Journal of Gastroenterology ·Francesca Colapietro, Daniele Piovani, Nicola Pugliese, Alessio Aghemo, Vincenzo Ronca, Ana Lleò	5
3	Decoding human Intrahepatic Cholangiocarcinoma Metabolism: Unveiling the Impact of SLC2A3 on Aggressiveness and Prognosis 2024 ·Digestive and Liver Disease ·(unknown), Barbara Franceschini, (unknown), Cristiana Soldani, Roberta Carriero, Alessio Aghemo, (unknown), (unknown), Roberta Pastorelli, Laura Brunelli, Ana Lleò	1
4	Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence 2023 ·Cancers ·(unknown), (unknown), Simone Famularo, Ana Lleò, Renzo Boldorini, Matteo Donadon, Guido Torzilli	6
5	Ursodeoxycholic Acid Does Not Improve COVID-19 Outcome in Hospitalized Patients 2023 ·Viruses ·Francesca Colapietro, Giovanni Angelotti, Chiara Masetti, Dana Shiffer, Nicola Pugliese, Stella De Nicola, F. Carella, (unknown), (unknown), Marta Calatroni, Paolo Omodei, Michele Ciccarelli, Stefano Aliberti, Francesco Reggiani, Michele Bartoletti, Maurizio Cecconi, Ana Lleò, Alessio Aghemo, Antonio Voza	12
6	Hepatitis C Virus Infection in the Elderly in the Era of Direct-Acting Antivirals: Evidence from Clinical Trials and Real Life 2023 ·Tropical Medicine and Infectious Disease ·Nicola Pugliese, Davide Polverini, (unknown), Stella De Nicola, Francesca Colapietro, Chiara Masetti, (unknown), Roberto Ceriani, Ana Lleò, Alessio Aghemo	5
7	Cellular Senescence in Liver Cancer: How Dying Cells Become “Zombie” Enemies 2023 ·Biomedicines ·(unknown), (unknown), Cristiana Soldani, (unknown), Barbara Franceschini, Ana Lleò, Eduardo Bonavita, Matteo Donadon	5
8	Reply: Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome—First report of the IAIHG retrospective registry 2023 ·Hepatology ·(unknown), Floris F. van den Brand, Ana Lleò, Rodrigo Liberal, Ynto S. de Boer	3
9	Tumor-Infiltrating B Lymphocytes: Promising Immunotherapeutic Targets for Primary Liver Cancer Treatment 2023 ·Cancers ·(unknown), Ana Lleò	6
10	A change of paradigm in PBC: Pursuing normal alkaline phosphatase 2022 ·EBioMedicine ·Ana Lleò	0
11	Clinical features and management issues of NAFLD-related HCC: what we know so far 2022 ·Expert Review of Gastroenterology & Hepatology ·Nicola Pugliese, (unknown), (unknown), Silvia Giugliano, Tommaso Lorenzo Parigi, María Rescigno, Ana Lleò, Alessio Aghemo	3
12	Contemporary Epidemiology of Primary Biliary Cholangitis 2022 ·Clinics in Liver Disease ·Francesca Colapietro, (unknown), Ana Lleò	18
13	Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors 2021 ·Cancers ·Nicola Personeni, Tiziana Pressiani, Antonio D’Alessio, (unknown), Silvia Bozzarelli, Luigi Terracciano, Arianna Dal Buono, Antonio Capogreco, Alessio Aghemo, Ana Lleò, Romano Fabio Lutman, Massimo Roncalli, Laura Giordano, Armando Santoro, Luca Di Tommaso, Lorenza Rimassa	11
14	Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis 2020 ·The Journal of Experimental Medicine ·Matteo Donadon, Guido Torzilli, Nina Cortese, Cristiana Soldani, Luca Di Tommaso, Barbara Franceschini, Roberta Carriero, Marialuisa Barbagallo, Alessandra Rigamonti, Achille Anselmo, Federico Colombo, (unknown), Ana Lleò, Javier Cibella, Clelia Peano, Paolo Kunderfranco, Massimo Roncalli, Alberto Mantovani, Federica Marchesi	110
15	Transcriptional Differences for COVID-19 Disease Map Genes between Males and Females Indicate a Different Basal Immunophenotype Relevant to the Disease 2020 ·Genes ·Tianyuan Liu, Leandro Balzano‐Nogueira, Ana Lleò, Ana Conesa	16
16	Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options 2020 ·Cancers ·Nicola Personeni, Ana Lleò, Tiziana Pressiani, Francesca Colapietro, Mark R. Openshaw, Chara Stavraka, (unknown), David J. Pinato, Lorenza Rimassa	32
17	The tumour microenvironment and immune milieu of cholangiocarcinoma 2019 ·Liver International ·Luca Fabris, María J. Perugorria, Joachim C. Mertens, Niklas K. Björkström, Thorsten Cramer, Ana Lleò, Antonio Solinas, Hanna Sänger, Veronika Lukacs‐Kornek, Anja Moncsek, Alexander Siebenhüner, Mario Strazzabosco	122
18	Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered 2019 ·Nutrients ·Maria Corina Plaz Torres, Alessio Aghemo, Ana Lleò, Giorgia Bodini, Manuele Furnari, Elisa Marabotto, Luca Miele, Edoardo G. Giannini	75
19	Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 2016 ·Clinical & Experimental Immunology ·Francesca Bernuzzi, Francesco Marabita, Ana Lleò, Marco Carbone, Massimiliano Mirolo, Marco Marzioni, Gianfranco Alpini, Domenico Alvaro, Kirsten Muri Boberg, Massimo Locati, Guido Torzilli, Lorenza Rimassa, Fabio Piscaglia, (unknown), Christopher L. Bowlus, G-X Yang, M. Eric Gershwin, Pietro Invernizzi	70
20	Geoepidemiology, Genetic and Environmental Risk Factors for PBC 2015 ·Digestive Diseases ·Haiyan Zhang, Marco Carbone, Ana Lleò, Pietro Invernizzi	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact